Description
Introduction
One of the leading infectious disease, HIV is taking a huge death toll across the globe, surpassing malaria and TB. Therapeutic HIV vaccines are designed for patients who have HIV with the aim to improve the body’s immune response to the disease. Preventive HIV vaccine is given to people who are not suffering from HIV, with the aim of preventing HIV infection in the future. Currently, there are no therapeutic and preventive HIV vaccines approved by the Food and Drug Administration (FDA), but research is under way. Therapeutic HIV vaccines are required to slack down the progression rate of HIV infection and to eliminate the need for antiretroviral therapy (ART) while still keeping undetectable levels of HIV. Also, therapeutic HIV vaccines will be utilized as part of a larger strategy to eliminate all HIV from the body.
Market Dynamics
The Preventive and Therapeutic Vaccine Market is expected to experience high growth in the forecasted period due to various factors such as an increase in the number of infected population, expansion of research and development funding for HIV vaccines, rise in the government spending for vaccine development, introduction of faster vaccine development technologies, and improvements in vaccine design. However, the stringent regulations for the approval of vaccines, complexity associated with research studies and low success rate in clinical trials for therapeutics hamper the market expansion.
Market Segmentation
The market for Preventive and Therapeutic Vaccine is segmented on the basis of technology type and phase of research. On the basis of technology, the market is categorized into toxoid, live attenuated, conjugate, recombinant, and inactivated & subunit. The conjugate vaccines have the largest market share due to massive government support for vaccine development and rising investments in R&D. In terms of phase of research, the market is classified into Preclinical, Clinical, Phase I, II, III, IV etc.
Regional/Geographic Analysis
The Preventive and Therapeutic Vaccine Market has enormous market opportunities around the world. Currently, U.S. enjoys the major market share because of the presence of large pharmaceutical industry base, best-in-class healthcare infrastructure, and high spending on healthcare by the citizens. The presence of advanced and active R&D establishment further fuel the growth. Europe is the second largest market after North America. Research, Development and Innovation conducted by various MNCs in the field of vaccine production are advantages for this region.
Key Players
The Global Preventive and Therapeutic Vaccine Market is mainly controlled by firms such as Pfizer, Merck, Sanofi, Novartis, Profectus Biosciences, Antigen Express, Bionor Pharmaceuticals, Celldex Therapeutics, Glaxo Smith Kline, Inovio Pharmaceuticals, Crucell Pharmaceutical, AlphaVax, FIT Biotech among others. An Increase in the prevalence of diseases in children and adults will generate demand for more preventive vaccine in coming years, providing market opportunities to these firms.
- Market segments
- Market Drivers, Restraints and Opportunities
- Market Size & Forecast 2016 to 2022
- Supply & Demand Value Chain
- Market – Current Trends
- Competition & Major Companies
- Technology and R&D Status
- Porters Five Force Analysis
- Strategic and Critical Success Factor Analysis of Key Players
- North America
- US and Canada
- Latin America
- Mexico, Brazil, Argentina and Rest of Latin America
- Western Europe
- EU5 (Germany, France, Italy, Spain, U.K.)
- Nordic Countries (Denmark, Finland, Norway, and Sweden)
- Benelux (Belgium, The Netherlands, and Luxembourg)
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
- Asia Pacific
- China
- India
- Japan
- Australia and New Zealand
- Rest of Asia Pacific
- Middle East and Africa
- GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
- South Africa
- North Africa
- Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
- Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
- Consumer and Pricing Analysis
- Market dynamics of the industry
- Market Segmentation
- Estimated Market Sizing in terms of volume and value
- Recent trends in Market and impact
- Research Status and Technology Overview
- Extensive Industry Structure Coverage
